These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33852098)

  • 1. ASO Author Reflections: Selective Nodal Staging and De-escalating Adjuvant Therapy.
    McKevitt E; Nichol A
    Ann Surg Oncol; 2021 Oct; 28(11):5958-5959. PubMed ID: 33852098
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: It is Essential to Explore More Accurate Nodal Staging System for Esophageal Cancer.
    Wang WP; Chen LQ
    Ann Surg Oncol; 2019 Apr; 26(4):1012-1013. PubMed ID: 30693452
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy.
    Deng W; Chen J; Xiao Z
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):802-803. PubMed ID: 31654164
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Multimodality Treatment in Esophageal Signet Ring Cell Adenocarcinoma.
    van Hootegem SJM; Wijnhoven BPL
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):796-797. PubMed ID: 31637607
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: More May Not Be Better.
    Worrell SG; Linden PA
    Ann Surg Oncol; 2020 Feb; 27(2):509-510. PubMed ID: 31673943
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: ypTNM Stage Grouping in the 8th Edition of the AJCC Cancer Staging Manual Refines the Prognostic Prediction for Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy.
    Sudo N; Ichikawa H; Muneoka Y; Hanyu T; Kano Y; Ishikawa T; Hirose Y; Miura K; Shimada Y; Nagahashi M; Sakata J; Kobayashi T; Bamba T; Nakagawa S; Kosugi SI; Wakai T
    Ann Surg Oncol; 2021 Feb; 28(2):661-662. PubMed ID: 33001302
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Perineural Invasion in pN0M0 Esophageal Squamous Cell Carcinoma: Let Pathology Strengthen the Clinical Oncology Practice.
    Guo YN; Su M
    Ann Surg Oncol; 2020 Oct; 27(11):4382-4383. PubMed ID: 32632885
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: TNM 8th Edition: Stage I Non-small Cell Lung Cancer-Free from Recurrence and Adjuvant Therapy? How to Predict?
    Zeng Y; Mayne N; Yang CJ; Liang W; He J
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):745-746. PubMed ID: 31555939
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Surgical Resection of Esophageal Neuroendocrine Tumors Should Be Considered as an Integral Part of Multimodal Therapy in Localized Disease.
    Erdem S; Worni M
    Ann Surg Oncol; 2020 Mar; 27(3):681-682. PubMed ID: 31741110
    [No Abstract]   [Full Text] [Related]  

  • 10. Ability of EUS with fine-needle aspiration to document nodal staging and response to neoadjuvant chemoradiotherapy in locally advanced esophageal cancer: a case report.
    Penman ID; Williams DB; Sahai AV; Hoffman BJ; Hawes RH
    Gastrointest Endosc; 1999 Jun; 49(6):783-6. PubMed ID: 10343229
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: A Novel Station-Based Nodal Staging System for Esophageal Squamous Cell Carcinoma.
    Yuan Y; Hong HG; Chen LQ
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):782-783. PubMed ID: 31605350
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined modality therapy of localized gastric and esophageal cancers.
    Das P; Fukami N; Ajani JA
    J Natl Compr Canc Netw; 2006 Apr; 4(4):375-82. PubMed ID: 16569390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based review of the management of cancers of the gastroesophageal junction.
    Narsule CK; Montgomery MM; Fernando HC
    Thorac Surg Clin; 2012 Feb; 22(1):109-21, vii-viii. PubMed ID: 22108695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, Part 2.
    Schefter TE; Patel M; McCarter M; Kane M; Russ PD; Nash SR; Shah RJ; Mitchell JD
    Oncology (Williston Park); 2005 Jun; 19(7):830, 835-6, 838 passim. PubMed ID: 16053033
    [No Abstract]   [Full Text] [Related]  

  • 15. [Perioperative therapy in esophageal and stomach carcinoma].
    Stahl M; Wilke H; Meyer HJ
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():85-92. PubMed ID: 8692126
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined modality treatment in oesophageal carcinoma.
    Maughan TS; Crosby TD
    Clin Oncol (R Coll Radiol); 1998; 10(6):354-5. PubMed ID: 9890534
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Is the Current Nodal Staging Systems for Pancreatic Cancer Applicable to all Possible Circumstances?
    Lee W; Kim SC
    Ann Surg Oncol; 2022 Jan; 29(1):399-400. PubMed ID: 34427822
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Effectiveness of Resection of Oligometastases from Esophageal Cancer.
    Ohkura Y
    Ann Surg Oncol; 2020 Mar; 27(3):660-661. PubMed ID: 31907746
    [No Abstract]   [Full Text] [Related]  

  • 19. Staging of esophageal carcinoma.
    Hagen JA; DeMeester TR
    J Thorac Cardiovasc Surg; 2003 May; 125(5):988-91. PubMed ID: 12771869
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Survival for Stage III Melanoma-Where Do We Stand in the Current Landscape of Melanoma Therapies?
    Song Y; Karakousis GC
    Ann Surg Oncol; 2019 Dec; 26(13):4631-4632. PubMed ID: 31576473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.